Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Advin Biotech is a commercial-stage manufacturer of FDA-cleared and CLIA-waived rapid diagnostic tests for drugs of abuse. Their products are used in medical settings, workplace testing programs, laboratories, and criminal justice organizations. The company’s portfolio includes urine and oral fluid drug tests with customizable panels covering all standard drugs of abuse as well as specialty assays such as EtG (alcohol metabolite), Tramadol, Fentanyl, Ketamine and the first US FDA-cleared 6AM test. Their products are known for high accuracy (>99%), fast results (<1 minute for negatives), U.S.-based manufacturing under GMP/QSR standards in San Diego CA with additional capacity in Hangzhou China[1][2][3][5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Advin Biotech.